The development of polyclonal tumours from clones with distinct Apc mutational profiles suggests that just right conditions for tumour initiation can be achieved by cooperation between founder clones reciprocating in their perturbation of APC–MYC and KRAS pathways. This evidence concerns the gene KRAS and neoplasm.